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The immune system represents the m ajor line of defence against microbial infections in vertebrates. It relies on two different, though connected, mech anisms: hum oral immune responses mediated by soluble im munoglobulins (antibodies) that are se creted by B lymphocyte-derived plasma cells, and cellular immune responses mediated by thymusderived T lymphocytes (T cells). The antigen-specific receptor molecules on B and T cells are clonally distributed, and their enormous polymor phism is created by irreversible rearrangement of B and T cell-specific genomic elements (V, D, J) during B und T cell ontogeny [1, 2] .
T cells are im portant in both cell-mediated and hum oral immune responses [3] . Their antigen spe cificity is determ ined by immunoglobulin-like T cell receptors (TCR), m ade up of a disulfide-linked glycoprotein heterodimer forming the antigenbinding site [2] , and o f a complex o f several nonpolym orphic m em brane proteins (the CD 3 com plex) [4] , responsible for signal transmission. U n like the im m unoglobulin receptor o f B cells [1] , the TC R repertoire is selected during thymic ontogeny to recognize antigens exclusively in the form of small peptides associated with membrane proteins encoded by the m ajor histocom patibility gene complex (M H C class I and class II antigens) [5] , a phenom enon termed M H C restriction [6] . The class specificity o f M HC restriction is determined by the accessory surface molecules CD 8 (class I M HC restriction) or C D 4 (class II M H C restric tion) [7] . C D 8 + T cells usually possess cytotoxic potential (cytotoxic T lymphocytes, CTL) and are essential in the elimination of virus-infected cells [8] . C D 4 + cells are normally involved in regulatory processes and therefore term ed helper T cells (TH) which mediate their function via soluble factors (lymphokines) [9] .
Both classes o f T cells are, however, not only in volved in beneficial defence reactions against mi crobial infections, but they are also responsible for immunological hyperreactivities such as the var ious types o f allergic disorders [10] . One typical type of allergy-inducing agent (allergen) is repre sented by low-molecular, chemically reactive, syn thetic chemicals or drugs [10] . Although these substances can be bound by specific antibodies, they may elicit immunereactions only after attach ment to soluble or cellbound proteins by covalent reaction or complexation. They have therefore been named "half-antigens" or haptens [11] .
Due to their chemically defined structure, hap tens have played a m ajor part in the elucidation of the specificity and the molecular structure of anti body binding sites [12] . T cells, in contrast, recog-nize hapten determ inants exclusively on haptenmodified cell surfaces, which usually involves a chemical reaction with complete cells [13, 14] . For these reasons, those hapten determ inants im m uno genic for T cells could not be structurally defined. In contrast to the binding o f antigen and antibody, haptens have therefore been of little help in the elucidation of the molecular details of T cell-antigen interactions.
Hapten-specific T cells
In vitro cultures o f hapten-specific CTL were first described in 1974 [13] . Shearer and his col leagues showed that class I M HC-restricted trinitrophenyl (TNP)-specific CTL could be induced in vitro by stim ulation with M HC-congenic cells which had been TNP-modified with trinitroben zene sulfonic acid (TNBS) (see Fig. 1 ). Num erous other chemical haptens have later been described to induce hapten-specific CTL [14] . Such T cells can be m aintained in perm anent cultures (CTL lines) and also cloned from single cells (CTL clones). It has even become possible to produce C D 8 + T cell hybridom as by fusion of CTL with variants of the thym om a line BW 5147 [16] . Antigen-specific stimulation of these hybridom as trig gers the release o f interleukin 2 (IL-2) [16] .
M any hapten-specific T cell reactions could be induced in cultures o f primary, i.e. non-immunized T cells, a phenom enon usually only observed with very strong antigens such as in T cell responses across M HC borders (allo-specific responses). The strength of the TNP-specific T cell responses has, therefore, often been explained by assuming M HC molecules, covalently modified with TNP ("altered self'), to be the m ajor hapten determ inants [17] . Nevertheless, CTL reactions against target cells modified with TNP-derivatized soluble proteins have also been described [17] [18] [19] . As indicated in Fig. 2 , chemical modification of cell surfaces with TNBS may thus lead to an extremely ill-defined m ultitude of different hapten determ inants.
Limited receptor repertoire in TNP-specific CTL
Studies of the TCR repertoire of allo-M HC-specific T cell populations have not revealed an ap parent selection for particular receptor elements [20] . This is easily understandable on the basis of the present knowledge on antigen recognition by T cells: a MHC-specific TCR is com plem entary not only to epitopes of the allo-M HC but also to epi topes formed by the complex o f M H C and the multitude of peptides bound to its "binding groove" [21, 22] . We were, therefore, extremely surprised to find the TCR repertoire o f M HC (H-2 K b)-restricted, TNP-specific CTL in the mouse to be clearly limited: almost half o f the CTL clones analyzed were found to have rearranged a member of the ValO gene family in their TC R a-chain in combination with a Jß2.6-containing ß-chain [15] , Moreover, a defined position at the V-J junctional region of the a-chains (position 93 according to Chothia et al. [23] ), was always occu pied by an acidic amino acid (glutamic (E) or as partic acid (D), see Fig. 3 ). Since even strictly de- fined antigenic epitopes are known to elicit a spec trum o f several "fitting" receptors, we concluded that the number of "T cell relevant" M H C-TN P epitopes on TNBS-modified cell surfaces must be small to allow for a measurable limitation of TC R heterogeneity.
MHC-binding TNP peptides
The apparent limitation o f T cell-antigenic TN P determ inants encouraged us to attem pt the identi fication of such structures. B. O rtm ann in our lab oratory [24] has recently succeeded in isolating, identifying and synthesizing TNP-lysine-containing peptides from TNBS-modified soluble proteins such as bovine or mouse serum albumin (BSA, MSA) or chicken ovalbumin (OVA). Three syn thetic peptides emerged from these studies (Fig. 4) which could be shown to associate to the class I M H C molecule H -2K b. Two of these peptides (TN P-BSA222-231 and T N P -M S A 126-135) ef ficiently sensitized K b-expressing target cells for lysis by cytotoxic T cell clones in a completely cross-reactive way. This was the case for 5 out of 12 independently raised CTL clones, specific for K b-expressing, TNBS-modified target cells. One additional clone selectively recognized TNP-O V A 258-267, whereas 6 clones failed to react with any of the 3 peptides. Thus, the 3 TN P pep tides identified TN P epitopes for about 50% of our in vitro selected TNP-specific CTL clones. In this context it is of interest that P. Romagnoli et al. [25] have recently reported that Ni-specific T cells, which occur in Ni-induced contact sensitivities, may be directed against MHC-associated Ni-peptide complexes.
Covalent MHC-TNP determinants are not important
However, for 50% o f our clones the target epi topes com plem entary to their TNP-specific recep tors remained unknown. We, therefore, asked the question whether these determ inants might be represented by covalently TNP-modified K b (alter ed self) molecules.
A. v. Bonin in our group has used the mouse lym phoma RM A-S, a m utant cell line expressing "em pty" (peptide-free) K b-molecules [26, 27] , as target cells for a collection o f T N P /K b-specific CTL. He found no evidence for an immunodominance o f "altered se lf' TNP epitopes and clearly dem onstrated that some of the clones were even devoid of any reactivity with covalently TNBSmodified RM A-S cells (submitted for publication). M HC molecules, covalently modified with TNP, can therefore, only play a m inor role as antigenic determ inants for TNP-specific CTL.
M oreover, it could be shown (A. v. Bonin, un published results) that several of our CTL clones specific for "unknow n" TNP epitopes reacted with target cells sensitized with peptide extracts pre pared from TNBS-modified K b-expressing spleen cells according to the method of H. G. Rammensee and coworkers [22, 28, 29] . This indicates that those CTL clones not reacting with the TN P pep tides shown in Fig. 4 are also specific for ^-a s s o ciated, though as yet unidentified, TN P peptides.
Role of peptides in determination of TNP epitopes
Recent data from H. G. Rammensee's [30] and other laboratories [31] [32] [33] have indicated haplotype-specific restrictions on size and amino acid sequence of naturally M HC-associated peptides. For K b-associated peptides the minimal structural requirements according to this analysis were as shown at the bottom o f Fig. 4 : a length of 8 amino acids, a phenylalanine (F) or tyrosine (Y) in posi tion 5, and a leucine (L) in position 8 [30] . S. M ar tin in our laboratory (data submitted for publica tion) could dem onstrate that trimming o f the decapeptide TNP-M SA 126-135 (Fig. 4) to the optimal length o f 8 amino acids (128-135) and substitu tion of the arginine at position 135 by leucine, i.e. full adjustm ent to the postulated m otif o f Falk et al. [30] , increased the antigenic efficacy o f the pep tide by a factor of > 104. This clearly points to the relevance of Rammensee's predictions and allows the directed synthesis o f hapten-bearing, K b-binding peptides.
Indeed, S. M artin found that several synthetic octapeptides obeying the rules for K b-specificity (F or Y in position 5 and L in position 8) but differing in their remaining amino acid sequences, produced K b-associated TNP epitopes cross-reactive with TNP-M SA 128-135, provided that they contained a TNP-conjugated lysine in position 4 (Fig. 5 A) . TNP-lysine in a different position (e.g. position 7, see Fig. 5 B) was not recognized by these clones.
These findings infer very clearly that the haptenbearing peptide mainly provides the function o f an "anchor" for the TNP residue in the M H C pep tide-binding groove. The amino acid sequence of the peptide anchor is of m inor im portance in the definition o f the hapten epitope. The main func tion o f the peptide sequence is, therefore, to define the position of lysine in the chain. Since lysine is the only am ino acid residue modified by TNBS [35] the positioning o f lysine in the peptide directly defines the localization of the hapten-determ inant in the TC R -contact-area of the M HC molecule (see Fig. 5 ).
Conclusions and Outlook
Our findings have several far-reaching implica tions:
1. The chemical synthesis o f high-affinity M HCbinding, hapten-conjugated peptides will allow the production o f stimulatory or target cells carrying only one defined type o f hapten epitope. This will dismiss the problem of heterogeneous and molecularly undefined antigenic hapten determinants and introduce a new level of structural specificity to studies on hapten-specific T cell systems. The use of defined M H C -anchor peptides will, for exam ple, allow their m odification with any desired chemical hapten. This opens the field of TCR hap ten interaction to studies on a level of molecular detail com parable to that known for antibodyhapten binding sites. In fact, comparisons o f pri mary TC R structures recognizing or not recogniz ing a given TN P-peptide/M H C complex have al ready led to the identification of hapten-contact ing TC R regions [36, 37] . Moreover, the new methodology opens the way to using photo-reac-tive haptens for photo-affinity labelling of antigen contact residues in specific T cell receptors.
2. A nother implication concerning basic re search on peptide-M H C interactions and the rec ognition o f these complexes by specific T cells is the following: In general, m anipulations on the se quence o f M HC-binding, antigenic peptides, aim ing at alterations o f the affinity of the peptide-M H C association, will lead to a simultaneous loss o f antigenic specificity. Here we show that within given rules the am ino acid sequence of TNP-anchoring peptides can be widely changed without interfering with the TCR-specific TN P epitope.
3. The more practical implications, finally, con cern our understanding o f allergic disorders. W hat are the reasons for some selected structures within the universe of antigens to force immuneresponses into the various types of allergic hyperreactivities? O ur data may bear on this question in that the nitrophenylated com pounds D N P and TN P are am ong the classical model reagents to induce delayed-type hyperreactivity or contact sensitivity.
T N P may be attached to any M HC-associating, lysine-containing peptide. M oreover, most if not all o f these peptides possessing a lysine residue in a defined position o f their sequence will give rise to cross-reactive, T cell-specific hapten epitopes. Thus, the num ber o f identical or cross-reactive TN P determ inants per cell, i.e. the repetitivity of individual epitopes, m ust be significantly higher for TN P than for the vast m ajority of "norm al" peptide antigens. Future experiments, involving stim ulatory cell populations of defined haptenpeptide surface density will have to decide whether this param eter, indeed, may direct immune re sponses into "norm al" or "hyper" reactivity. The facts that our TN P peptides can be traced with TNP-specific antibodies, and that we can produce cross-reactive TNP peptides of highly varying affinity for M HC are definitely helpful in this respect.
The affinity of peptides for their M H C binding sites may represent a link between protein and hapten allergens. Protein determ inants represent ed by processed peptides of extraordinarily high MHC affinity should become over-represented and produce more repetitive determ inants than other peptides on antigen presenting cells.
Given the new technology available for produc ing class I M HC-associated hapten determ inants for T cells (hopefully soon to be applicable also to class II MHC) we feel that many o f these questions may now be experimentally answered. This, in turn, should lead to a more detailed understanding of chemically and drug-induced allergic diseases.
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